⌘K

Login Start Free

Home/Filings/4/0001127602-18-023857

4//SEC Filing

Molho Davide 4

Accession 0001127602-18-023857

CIK 0001100682other

View on SEC.gov Company Profile

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 6:45 PM ET

Size

12.1 KB

Accession

0001127602-18-023857

Insider Transaction Report

Form 4

Period: 2018-07-24

CHARLES RIVER LABORATORIES INTERNATIONAL INCCRL

Corporate Executive VP

Transactions

Exercise/Conversion
Common Stock
2018-07-24$73.70/sh+8,375$617,238→ 35,928 total
Sale
Common Stock
2018-07-24$125.00/sh−18,773$2,346,625→ 17,155 total
Exercise/Conversion
Stock Options (Right to Buy)
2018-07-24−8,375→ 16,749 total
Exercise: $73.70From: 2017-02-26Exp: 2021-02-26→ Common Stock (8,375 underlying)
Exercise/Conversion
Common Stock
2018-07-24$59.41/sh+5,474$325,210→ 27,553 total
Exercise/Conversion
Stock Options (Right to Buy)
2018-07-24−5,474→ 0 total
Exercise: $59.41From: 2015-02-28Exp: 2021-02-28→ Common Stock (5,474 underlying)

Holdings

Common Stock
(indirect: By Trust)
40,748

Footnotes (1)

[F1]This sale occurred pursuant to a 10b5-1 Trading Plan.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL INC

CIK 0001100682

Entity typeother

Related Parties

1

filerCIK 0001507332

Filing Metadata

Form type: 4
Filed: Jul 24, 8:00 PM ET
Accepted: Jul 25, 6:45 PM ET
Size: 12.1 KB

View on SEC.gov